Literature DB >> 29222379

8. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2018.

.   

Abstract

The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
© 2017 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29222379     DOI: 10.2337/dc18-S008

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  242 in total

Review 1.  Glucose-Lowering Therapies for Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: State-of-the-Art Review.

Authors:  Salvatore Carbone; Dave L Dixon; Leo F Buckley; Antonio Abbate
Journal:  Mayo Clin Proc       Date:  2018-11       Impact factor: 7.616

2.  A tool for empirical equipoise assessment in multigroup comparative effectiveness research.

Authors:  Kazuki Yoshida; Daniel H Solomon; Sebastien Haneuse; Seoyoung C Kim; Elisabetta Patorno; Sara K Tedeschi; Houchen Lyu; Sonia Hernández-Díaz; Robert J Glynn
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-05-27       Impact factor: 2.890

3.  Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride.

Authors:  Elisabetta Patorno; Sebastian Schneeweiss; Chandrasekar Gopalakrishnan; David Martin; Jessica M Franklin
Journal:  Diabetes Care       Date:  2019-06-25       Impact factor: 19.112

4.  Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic Cancer-Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study.

Authors:  Jaelim Cho; Robert Scragg; Stephen J Pandol; Mark O Goodarzi; Maxim S Petrov
Journal:  Diabetes Care       Date:  2019-06-21       Impact factor: 19.112

Review 5.  Sodium-glucose cotransporter inhibitors in type 2 diabetes: thinking beyond glucose lowering.

Authors:  Brendon L Neuen; David Z Cherney; Meg J Jardine; Vlado Perkovic
Journal:  CMAJ       Date:  2019-10-15       Impact factor: 8.262

6.  Lipid-Lowering Prescription Patterns in Patients With Diabetes Mellitus or Cardiovascular Disease.

Authors:  Alanna M Chamberlain; Sarah S Cohen; Jill M Killian; Keri L Monda; Susan A Weston; Ted Okerson
Journal:  Am J Cardiol       Date:  2019-07-15       Impact factor: 2.778

Review 7.  Diabetes pharmacotherapy and effects on the musculoskeletal system.

Authors:  Evangelia Kalaitzoglou; John L Fowlkes; Iuliana Popescu; Kathryn M Thrailkill
Journal:  Diabetes Metab Res Rev       Date:  2018-12-20       Impact factor: 4.876

8.  Association of Second-line Antidiabetic Medications With Cardiovascular Events Among Insured Adults With Type 2 Diabetes.

Authors:  Matthew J O'Brien; Susan L Karam; Amisha Wallia; Raymond H Kang; Andrew J Cooper; Nicola Lancki; Margaret R Moran; David T Liss; Theodore A Prospect; Ronald T Ackermann
Journal:  JAMA Netw Open       Date:  2018-12-07

9.  Differences in National Diabetes Treatment Patterns and Trends between Older and Younger Adults.

Authors:  Scott J Pilla; Jodi B Segal; G Caleb Alexander; Cynthia M Boyd; Nisa M Maruthur
Journal:  J Am Geriatr Soc       Date:  2019-01-31       Impact factor: 5.562

10.  Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Melanie J Davies; David A D'Alessio; Judith Fradkin; Walter N Kernan; Chantal Mathieu; Geltrude Mingrone; Peter Rossing; Apostolos Tsapas; Deborah J Wexler; John B Buse
Journal:  Diabetologia       Date:  2018-12       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.